- Live market news
- Stocks
- IMMX
Immix Biopharma Inc
IMMXStockUSA
Latest news on IMMXranked by Oyticker for market impact
- 45Impact
Immix Biopharma prices $125M equity offering at $11/share
Immix Biopharma announced pricing of 11.36M shares at $11.00/share in an underwritten offering, raising $125M gross proceeds before fees. The offering is expected to close September 30, 2026.
IMMXBiotechnologyPharmaceuticals - 72Impact
Immix Biopharma reports 89% CR rate in NEXICART-2 interim AL amyloidosis trial
Immix Biopharma announced interim NEXICART-2 data showing 89% complete response rate across all enrolled patients, with 100% of 25 new patients achieving CR or MRD-negative status, suggesting potential for up to 98% CR rate if MRD-negative patients convert.
IMMXBiotechnologyPharmaceuticals
SEC filings
All its filingsWhat IMMX filed
- 30 Sept 2026
- 29 Sept 2026
Other event
- 7 Aug 2026
- 20 Jul 2026
- 29 May 2026
- 21 May 2026
- 21 May 2026
Other event
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.